英文别名 |
Isoquinoline,
2-[(2S)-3,3-dimethyl-1-oxo-2-[(4-pyridinylmethyl)amino]butyl]-1,2,3,4-tetr
ahydro-6,7-dimethoxy-;TCS OX2 29;TCS OX2 29,(2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-[(4-pyridinylmethyl)amino]-1-butanonehydrochloride;(2S)-1-(3,4-Dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)-3,3-diMethyl-2-[(4-pyridinylMethyl)aMino]-1-butanonehydrochloride;8-Bromo-cGMP,sodium salt;TCS-OX2-29;1-Butanone,1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-(4-pyridinylmethyl)amino-,(2S)-;(2S)-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethyl-2-(pyridin-4-ylmethylamino)butan-1-one;compound 29 [PMID: 14643355];GTPL4038;BDBM50136694;s6717;Q12747053;(S)-1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethyl-2-[(pyridin-4-;CID 10408514;(S)-1-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-3,3-dimethyl-2-((pyridin-4-ylmethyl)amino)butan-1-one;NCGC003;KB-11822;KH2US47J8R;372523-75-6;HB3225;(2S)-2-(4-Pyridylmethylamino)-1-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)-3,3-dimethylbutan-1-one;(S)-1-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-3,3-dimethyl-2-(pyridin-4-ylmethylamino)butan-1-one;TCS-OX 2-29;C23H31N3O3.2HCl;NCGC00370876-01;(2S)-1-(6,7-DIMETHOXY-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)-3,3-DIMETHYL-2-[(PYRIDIN-4-YLMETHYL)AMINO]BUTAN-1-ONE;1-Butanone, 1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-((4-pyridinylmethyl)amino)-, (2S)-;HY-100452;TCS-OX2-29?;CHEMBL142009;EX-A1454;AKOS032944970;Orexin antagonist TCS-OX2-29;(2S)-1-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-((4-pyridinylmethyl)amino)-1-butanone;SCHEMBL264626;Isoquinoline, 2-((2S)-3,3-dimethyl-1-oxo-2-((4-pyridinylmethyl)amino)butyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-;(S)-1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethyl-2-[(pyridin-4-ylmethyl)-amino]-butan-1-one;CS-5761;BS-17144 |